TSANZ home

Results for "strategic plan"

Home 5 Search query for: strategic plan
Results for "strategic plan"
VOLUME 7.06 – JULY 2022

VOLUME 7.06 – JULY 2022

Research Roundup:

July 2022

Welcome Message

Welcome to another issue of Research Roundup. Best of luck to everyone who applied for the recent Medical Research Future Fund grants. I hope you have all caught up on some sleep by now!

Speaking of grants there is a whole host of opportunities listed in this newsletter and quite a few are closing soon. TSANZ has two travel grants closing at the start of August, one for the inaugural TSANZSRS Education Hub, and one for the TSANZSRS NZ Branch ASM. Speaking of the NZ Branch ASM, their new investigator award closes on the 14th of August. Outside of TSANZ Cure4CF’s Holckner Family CF Impact Grant is offering up to $500,000 for Cystic Fibrosis research and this grant closes on the 5th of August. For those working outside of research ELF has grants of up to €1,000 for not-for-profit organisations, patient groups and healthcare professionals closing very soon, on the 31st of July.

In addition, the TSANZSRS ASM abstract linked awards have just opened! Details for these awards are outlined below. In related and exciting news, the value of both the Ann Woolcock New Investigator Award and Janet Elder International Travel Awards have increased to $5k each. A lot of the abstract linked awards are targeted to early-mid career researchers. If you fit into this category and have been thinking about submitting an abstract to TSANZ, you should absolutely consider extending your application to go for one, or even both of these awards at the same time. It may just be the steppingstone that takes you that little bit further along your career path.

The Limbic, Respirology and Respiratory Research Review have some excellent reads, and if you’re after further educational opportunities there are some interesting webinars across the next week. RACP are running a COVID webinar series in July, there’s one more session you can catch on the 28th; “COVID-19: Where to now?”. Next month on the 3rd of August ACTnet running a seminar on TB genomics.

Finally, if you ever find yourself feeling a little deprived of motivation, I strongly suggest a google search for Admiral McRaven’s 2014 commencement speech. He outlines 10 life lessons from his time as a navy seal…no wait, don’t stop reading yet. Seriously. I now have each of these printed on 10 A4 pieces of paper on the wall in my office. He has been and continues to be a source of inspiration for me, and for those of you who may be looking for that little push to open your next grant application template, this may be the productive procrastination activity for you.

As always, happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

TSANZSRS NZ Branch Meeting 2022 New Investigator Award – Abstract Submissions close 14th August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

TSANZSRS Annual Scientific Meeting 2023

Call for Abstracts

On behalf of the Organising Committees, we warmly invite you to attend the Annual Scientific Meeting of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand. The TSANZSRS 2023 meeting will be held at Te Pae Christchurch Convention Centre from 25th – 28th March 2023 with opportunities to attend pre-conference Postgraduate Courses on Friday 24th March.

TSANZ abstract awards are now open!

For more information regarding the TSANZSRS 2023 ASM and how to apply for the above awards visit https://www.tsanzsrsasm.com/

 

TSANZ Surveys

Help us improve our educational offerings to members and our skill base by completing the below surveys!

TSANZ Methodology Survey

Evidence-based practice skills among members of the TSANZ

The TSANZ is conducting this voluntary survey to identify members who have specific evidence-based practice (EBP) methodology skills to support the production of position statements and clinical practice guidelines by the Society.

We are asking you to fill out a questionnaire, which should take approximately 15 minutes to complete.

The study gives you an opportunity to tell us about:

  • The skills you have to perform specific elements of a systematic review for the development of Society documents
  • Your interest to learn/improve specific skills or share/teach specific skills

Survey link: https://forms.office.com/r/W6SUisW70g

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Education Hub Logo

Education Hub Travel Grants

The TSANZ and ANZSRS have established a scheme to assist early-career members to attend the TSANZSRS Education Hub. This is to encourage active participation in the Hub and will be awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields.

The travel grant for the 2022 TSANZSRS Education Hub will be to contribute to travel costs to maximum of AU$250*
* based on individual travel requirements with submitted evidence of costs.

Please click here for more information on the travel grant guidelines and eligibility criteria!

Please click here to register for the TSANZSRS Education Hub!

Respirology – Editor’s Choice

Respirology Issue 27.8 August 2022

Inhalational Exposures in Patients with Fibrotic Interstitial Lung Disease: Presentation, Pulmonary Function, and Survival in the Canadian Registry for Pulmonary Fibrosis

Cathryn T. Lee,Mary E. Strek,Ayodeji Adegunsoye,Alyson W. Wong,Deborah Assayag,Gerard Cox,Charlene D. Fell,Jolene H. Fisher,Andrea S. Gershon,Andrew J. Halayko,Nathan Hambly,Nasreen Khalil,Martin Kolb,Stacey D. Lok,Hélène Manganas,Veronica Marcoux,Julie Morisset,Mohsen Sadatsafavi,Shane Shapera,Teresa To,Pearce Wilcox,Christopher J. Ryerson,Kerri A. Johannson

DOI: 10.1111/resp.14267

 

External Grant Opportunities

European Lung Foundation Healthy Lungs for Life Grants

European Lung Foundation (ELF) is offering grants to support Healthy Lungs for Life activities.

Not-for-profit organisations, patient groups and healthcare professionals can apply for a grant of up to €1,000 to support events and activities that meet one or more of the aims of the Healthy Lungs for Life campaign:

Increase knowledge of the impact of poor air quality on lung health and the actions that everyone can take to reduce air pollution and avoid exposure
Highlight the benefits of quitting smoking
Increase knowledge of the importance of physical activity for lung health
Raise awareness of vaccination to prevent lung infections
This year we also strongly welcome applications linked to the topic of climate change and lung health.

Applications are now open for events focused on World Lung Day and awareness days later in 2022. The closing date for applications is 31 July 2022. To find out more and apply please follow this link.

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

Perspectives on Telehealth for the care of patients with Interstitial Lung Disease (ILD)

We are recruiting health professionals who are involved in the care of patients with Interstitial lung disease (ILD) to participate in this research project. Telehealth for ILD provides an opportunity to improve access to healthcare for patients. Its use has rapidly increased during the COVID-19 pandemic, however there is still a high level of dissatisfaction with telehealth amongst both patients with ILD and healthcare professionals. This study will help us to understand the opinions and experiences of patients with ILD, their caregivers and health professionals of using telehealth in the management of ILD, and ways in which the model can be improved.

Participation in the study will involve taking part in one interview, either in person, over the phone or via zoom. If you are interested in participating or would like further information on this study, please contact:
Dr Sheetal Deshpande
Phone: 03 9903 0214
Email: sheetal.deshpande1@monash.edu

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

Climate Change and Health – WA Healthcare Professionals Survey

The University of Western Australia and Department of Health WA are interested in your views on climate change and health. The information gathered through this project will be used to develop public health messaging and resources for both community and health professionals.

All WA healthcare professionals and healthcare workers with direct client or patient care contact are encouraged to participate. The survey is open from 18 July 2022 to 15 August 2022 and can be accessed online at https://consultation.health.wa.gov.au/pahd-sdu/climate-change-and-health/, and will take approximately fifteen minutes to complete.

Queries can be directed to Sarah Joyce at the Western Australia Department of Health, via email at sarah.joyce@health.wa.gov.au, or by phone on (08) 9222 4017.

LFA COVID-19 Survey

Lung Foundation Australia (LFA) are currently running a survey to gain an understanding of how COVID-19 has impacted Australians and what healthcare, information and support may be needed to help people manage ongoing symptoms. If you’ve had COVID-19 or cared for someone who has, LFA would love to hear your experience by completing this 5-10 minute survey. Completing the survey will put you in the running to win a $150 Visa gift card!

Even if you haven’t had COVID-19, you can share your experience on the government response during the pandemic and the impact of the pandemic on your access to healthcare.

Webinars and Seminars

RACP COVID-19

The RACP COVID-19 Expert Reference Group invites you to attend the upcoming July COVID webinar series.

The RACP have hosted a number of COVID-19 webinar series over the past couple of years in order to inform doctors about important COVID-19 matters, discuss key information and share learnings. We have a great line-up of panellists detailed below and are looking forward to some really engaging discussions.

Please register via the link to attend: REGISTRATION LINK

CALL FOR WEBINAR QUESTIONS – 28 JULY

Do you have any burning questions that you would like us to ask at the webinars? Please send them through to COVIDERG@racp.edu.au.

COVID-19: Where to now?

Thursday 28 July, 6pm-7.30pm AEST / 8pm-9.30pm NZST

This webinar will provide attendees with an understanding of some of the lessons learned though the COVID-19 pandemic and how they might be applied moving forward. The webinar will be in the format of an open panel discussion to guided questions as well as Q&A from webinar attendees.

Hosted by:
Dr Susan Graham, rehabilitation physician and Chair of the RACP COVID-19 Expert Reference Group
Associate Professor Asha Bowen, Head, Skin Health Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute and member of the RACP COVID-19 Expert Reference Group

Expert panellists include:
Professor Paul Kelly, Chief Medical Officer, Department of Health
Professor Christopher Blyth, Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Paediatric Infectious Diseases Physician and Clinical Microbiologist
Professor John Massie, Respiratory Physician and Clinical Director, Children’s Bioethics Centre, Royal Children’s Hospital
Dr Paresh Dawda, General Practitioner, Director and Principal Prestantia Health and Next Practice Canberra
Helen Kulas, NSW Respiratory Network Manager
Professor Peter Wark, Senior Staff Specialist – Respiratory and Sleep Medicine, John Hunter Hospital; Co-Chair NSW Respiratory Network

ACTnet TB Genomics Seminar

Whole genome sequencing of Mycobacterium tuberculsosis is increasingly being
implemented for antimicrobial resistance prediction and transmission surveillance. Join us as our expert panellists discuss the application of this technology for TB control.

When: 3rd August 2022
Time: 1200pm-1330pm (AEST)
Register: Here

Speakers

Dr Chris Coulter, QLD MRL – Topic: Introduction TB to Genomics
Dr Chris Coulter is a Microbiologist, the Chair of TB Expert Advisory Group for Tuberculosis in Queensland, and the Director of the Queensland Mycobacterium Reference Laboratory

Dr Norelle Sherry – Topic: Implementation of TB Genomics for Antimicriobial Resistance Prediction and Public Health
Dr Norelle Sherry is an Infectious Diseases Physician & Clinical Microbiologist, co-appointed at MDU-PHL and Austin Health, with a special interest in antimicrobial resistance (AMR). She is also a clinician-researcher, investigating the use of genomics for surveillance of antimicrobial resistance in multiple different settings, and translation of genomics from the research lab into clinical use.

Prof Vitali Sintchenko – Topic: Case Studies in TB Genomics
Professor Vitali Sintchenko is a leading public health microbiologist and informatician who conducts research on biosurveillance of communicable diseases. He is a Fellow of the Royal College of Pathologists of Australasia and the Australian College of Health Informatics. As the Director of CIDM-Public Health (a translational research hub funded by NSW Health), he leads a public health and diagnostic microbiology team working toward improving laboratory and epidemiological. investigations of communicable diseases.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 6.05 – JULY 2021

Research Roundup:

May 2021

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

Enjoy the May edition of your Research Roundup.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

$300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

(Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

“This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

“We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

“The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

TSANZ would like to congratulate the following Award winners.

TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

Open Awards

Thoracic Society Awards

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

Asthma Australia Research Grant and Workshop

Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

  • Aboriginal and Torres Strait Islander People
  • People facing socioeconomic disadvantage
  • People from culturally and linguistically diverse backgrounds.

We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

    Workshop  details

    1. Culturally and linguistically diverse backgrounds

    When: Wednesday 26th May 11-12:30
    Where: Ethnic Community Council Victoria

    1. People facing socioeconomic disadvantage
      Tuesday 25th May 2-3:30pm
    1. Aboriginal and Torres Strait Islander People
      TBC – please register interest

    If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

    2021 Australian Museum Eureka Prizes

    Do you know someone making a difference in their field?

    Entries to the 2021 Australian Museum Eureka Prizes are now open!

    This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

    There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

    If you know an individual or team doing outstanding work, why not encourage them to enter?

    Entries close 7pm AEST Friday 28 May

    VIEW THE FULL PRIZE PROGRAM

    Respirology – Editor’s Choice

    Respirology Issue 26.4 April 2021

    Central airway collapse is related to obesity independent of asthma phenotype

    Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

    DOI: 10.1111/resp.14005

    Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

    Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

    DOI: 10.1111/resp.13978

    Surveys and Research

    SURVEY OF LUNG CANCER CARE IN AUSTRALIA

    We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

    • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
    • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
    • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

    Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

    Thank you for your time.

    Prof Fraser Brims
    Curtin Medical School
    fraser.brims@curtin.edu.au 

    GP PARTICIPATION REQUIRED

    Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

    Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

    All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

    The survey can be accessed by clicking HERE.

    The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

     

    TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

    A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

    This study has now been completed and below is a summary of the findings from this work.

    The top 3 priorities rank by people with PF and caregivers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. What medications can improve lung function in people with PF?
    3. What are the causes of PF?

    The top 3 priorities rank by people with healthcare professionals/researchers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. How can we prevent PF?
    3. What are the causes of PF?

    The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

    (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

    The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

    Yours sincerely,

    Anne Holland
    Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

    TBPod

    The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

    Can you help TSANZ make a difference?

    Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

    1. Making a donation to our Benevolent Fund

    The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
    CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    2. Making a donation to support research

    With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
    Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    3. Establishing a named award

    For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

    4. Leave TSANZ a gift in your will

    If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
    If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

    5. TSANZ New Zealand Branch Incorporated 

    New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
    CLICK HERE to make a donation.

    Thank you for your continued support of TSANZ.

    VOLUME 7.06 – JULY 2022

    VOLUME 6.04 – MAY 2021

    Research Roundup:

    May 2021

    Welcome Message

    Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

    I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

    We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

    Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

    Enjoy the May edition of your Research Roundup.

    A/Prof Kristin Carson-Chahhoud
    Chair, Research Sub-Committee 

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    $300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

    (Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

    This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

    “This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

    “We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

    Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

    “The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

    The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    TSANZ would like to congratulate the following Award winners.

    TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

    BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

    Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

    TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

    TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

    TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

    Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

    PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

    Open Awards

    Thoracic Society Awards

    TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

    TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

    Asthma Australia Research Grant and Workshop

    Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

    At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

    • Aboriginal and Torres Strait Islander People
    • People facing socioeconomic disadvantage
    • People from culturally and linguistically diverse backgrounds.

    We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

    At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

      Workshop  details

      1. Culturally and linguistically diverse backgrounds

      When: Wednesday 26th May 11-12:30
      Where: Ethnic Community Council Victoria

      1. People facing socioeconomic disadvantage
        Tuesday 25th May 2-3:30pm
      1. Aboriginal and Torres Strait Islander People
        TBC – please register interest

      If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

      2021 Australian Museum Eureka Prizes

      Do you know someone making a difference in their field?

      Entries to the 2021 Australian Museum Eureka Prizes are now open!

      This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

      There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

      If you know an individual or team doing outstanding work, why not encourage them to enter?

      Entries close 7pm AEST Friday 28 May

      VIEW THE FULL PRIZE PROGRAM

      Respirology – Editor’s Choice

      Respirology Issue 26.4 April 2021

      Central airway collapse is related to obesity independent of asthma phenotype

      Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

      DOI: 10.1111/resp.14005

      Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

      Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

      DOI: 10.1111/resp.13978

      Surveys and Research

      SURVEY OF LUNG CANCER CARE IN AUSTRALIA

      We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

      • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
      • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
      • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

      Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

      Thank you for your time.

      Prof Fraser Brims
      Curtin Medical School
      fraser.brims@curtin.edu.au 

      GP PARTICIPATION REQUIRED

      Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

      Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

      All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

      The survey can be accessed by clicking HERE.

      The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

       

      TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

      A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

      This study has now been completed and below is a summary of the findings from this work.

      The top 3 priorities rank by people with PF and caregivers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. What medications can improve lung function in people with PF?
      3. What are the causes of PF?

      The top 3 priorities rank by people with healthcare professionals/researchers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. How can we prevent PF?
      3. What are the causes of PF?

      The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

      (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

      The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

      Yours sincerely,

      Anne Holland
      Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

      TBPod

      The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

      VOLUME 7.06 – JULY 2022

      VOLUME 4.02 APRIL 2019

      Research Roundup:

      April 2019

      .
       

      Welcome Message

      The TSANZSRS19 was a great success and we thank all delegates and exhibitors for supporting respiratory research and professional development once again.

      At TSANZSRS19 respiratory research received a much needed boost of funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and the Gala Dinner. Please find a re-cap of all the Thoracic Society Board Awards and Research Awards below, including the winners of the Special Interest Group Awards.

      During the conference we opened a number of larger TSANZ awards, namely the AstraZeneca Respiratory Research Fellowships, which will support one early-career researcher and one mid-career researcher and the Vertex Cystic Fibrosis Research Awards, which will support one adult CF research project and one paediatric CF research project. There are also opportunities for IPF PhD scholarships and Menarini travel awards from the Lung Foundation. Links to these awards can be found in the Open Awards section below.

      Enjoy the April edition of your research roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      $1 MILLION FOR LUNG DISEASE RESEARCH ANNOUNCED

      Top lung health bodies raise much needed funds but more investment needed

      (Thursday, 8th April 2019): Over a million dollars in lung research investment was announced over the weekend at the Respiratory Research Excellence Awards at the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science(TSANZSRS19) on the Gold Coast. The conference brings together Australia and New Zealand’s leading lung health experts to present latest research and improve knowledge and understanding of lung disease.

      The Research Excellence Awards, run for the second year by Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of the conference – alongside the Lung Foundation, Cystic Fibrosis Australia and the National Asthma Council of Australia, provides over 40 researchers with support in the form of project funding, fellowships and travel grants raised through private donations, sponsorship and leveraged financing from recipients’ institutions.

      “We’re honoured to be able to support some of Australia’s greatest minds in lung disease research; research that’s making a difference to the lives of the 1 in 4 Australians with lung disease,” said TSANZ President Elect Professor Bruce Thompson.

      “This funding enables our researchers to build respiratory knowledge and capacity in the respiratory workforce, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” he said.

      Despite the success of the Awards, the organisers warn that lung disease research is still grossly underfunded when compared to other diseases. Far more investment is required, they say.

      “It’s important to recognise the exceedingly hard work that our organisations are putting in to raising the profile of respiratory research, and to express our thanks for the contribution of donors, sponsors and institutions This is only our second year and look at what we’ve achieved,” said TSANZ CEO Tanya Buchanan.

      “However, fundraising alone is not the way to manage diseases affecting a quarter of Australians. Lung disease has to attract the same level of research funding enjoyed by other disease areas such as breast, prostate, and heart disease. We look forward to seeing if the implementation of the National Strategic Action Plan for Lung Conditions delivers this,” she said.

      2019 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

      TSANZ would like to congratulate the following Award winners. For information on how to apply for next year’s Awards visit the TSANZ website Research and Awards page.

      Society Medal

      Professor Helen Reddel

      Research Medal

      Professor Philip Hansbro

      Laennec Medal

      Professor Allan R Glanville

      Ann Woolcock New Investigator Award

      Jesse Armitage

      Best training Video

      Elizabeth Salamon, Selena West, Ursula Swan, Sandra Daly

      CSL Behring TSANZ / LFA Alpha-1 Anti-trypsin Deficiency Research Award

      Gang Liu

      Australian Cystic Fibrosis Research Trust Innovation Grant

      Gerard Kaiko, Peter Wark, Shafagh Water, and Adam Jaffe

      TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship

      Kimberly Wang

      Boehringer Ingelheim COPD Research Award 2019

      Tatt Jhong Haw

      Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

      Jane Bourke and Ryan Hoy

      Boston Scientific Research Award for Interventional Pulmonology

      Sanjeevan Muruganandan

      Vertex Cystic Fibrosis Research Awards

      ECFS: Elena Schneider-Futschik

      NACFC: Rebecca Stockwell

      TSANZ Peter Phelan Research Award

      Elena Schneider-Futschik

      TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health

      Gabrielle McCallum

      TSANZ / Boehringer Ingelheim Australia COPD Travel Award

      Alen Faiz

      TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award

      Eskandarain Shafuddin

      TSANZ/JRS Early Career Development Award

      Jemma Seyfang

      Janet Elder International Travel Awards

      Mid-Career Award Recipient: Kimberley Wang

      Early Career Award Recipient 1: Vikas Goyal

      Early Career Award Recipient 2: Yet H Khor

      TSANZ Respiratory Nurse Career Development Award for Indigenous Research

      Betty Poot

      Christine Sullivan

      Maurice Blackburn ASM Travel Award

      Leona Dowman

      Shine a light a lung cancer PhD 2019

      Kanishka Rangamuwa

      David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis Research 2019

      Archana Gaikwad

      Shine a light on lung cancer grant-in-aid

      Surein Arulananda

      Lung Foundation Australia/ Eleanor Greenwood Memorial Grant in Aid for Interstitial Lung Disease Research

      Yet Hong Khor

      Lung Foundation Australia /Lizotte Family Research Award for Interstitial PF Research

      Leona Dowman

      Lung Foundation Australia /Ludwig Engel GIA for Physiological research

      Katrina Tonga

      Lung Foundation Australia /Ivan Cash Research GIA – IPF

      Adelle Jee

      Lung Foundation Australia /Cochrane

      Jenifer Liang

      Shine a light on lung cancer nursing/allied health fellowship in lung cancer research

      Vanessa Brunelli

      Lung Foundation Australia Travel Awards: Menarini Travel Grants

      ERS – Hannah O’Farrell and Jack Bozier

      ATS – Thomas Altree and Razia Zakarya

      APSR – Leanne Ross and Hai Bac Tran

      Lung Foundation Australia/Eleanor Greenwood Memorial ILD Travel Grant

      Cecilia Prele

      Michael Schuliga

      Jade Jaffar

       

      SIG AWARDS

      Supported by TSANZ

      Cell, Immunology and Molecular Biology: Dhammika Leshan

      Evidence-based Medicine and Practice: Yet Hong Khor

      Peter van Asperen Paediatric: Kiara Sclip

      Physiotherapy: Jamie Wood

      Respiratory Infectious Disease: Benjamin Diggins

      Tobacco: Henry Gomez

      Supported by Asthma Australia

      Asthma & Allergy: Teresa Williams

      Supported by National Asthma Council

      Asthma & Allergy : Cherry Thompson

      Supported by Lung Foundation Australia

      Pulmonary Physiology and Sleep, John Reid Prize: Graeme Zosky

      David Serisier Memorial Award for Translational Research in Bronchiectasis: Su Wei Khung

      Supported by Cystic Fibrosis Australia

      Cystic Fibrosis: Elena Schneider-Futschik

      Supported by Maurice Blackburn

      Lung Cancer: Lara Edbrooke

      Occ Env Lung Disease / Population Health: Edward Harris

      Palliative Care and Symptom Support: Thomas Moran

      Supported by Carroll & O’Dea

      Interventional Pulmonology and Bronchoscopy: Deirdre Fitzgerald

      Supported by Boehringer Ingelheim

      Orphan Lung Diseases, Lung Transplant, Interstitial Lung Disease and Pulmonary Vascular Disease: Jemma Seyfang

      Primary Care: Mary Roberts

      Chronic Obstructive Pulmonary Disease: Sonia Cheng

      Respiratory Nurses: Jane Neil

      TSANZ Best Poster: Kris Nilsen: A new tool to monitor disease in IPF

      CONGRATULATIONS TO…

      TSANZ would also like to take this opportunity to congratulate the following New Fellows for 2019:

      • Prof Anne Holland
      • Dr Denise O’Driscoll
      • Dr Jane Bourke
      • A/Prof Jeff Garrett
      • Prof Paul Foster
      • Prof Peter Eastwood
      • Prof Sandra Hodge

       

      Open Awards

      Thoracic Society Awards

      AstraZeneca Respiratory Research Fellowships – closes 2nd June 2019

      Vertex Adult Cystic Fibrosis Research Award – closes 2nd June 2019

      Vertex Paediatric Cystic Fibrosis Research Award – closes 2nd June 2019

      Lung Foundation Awards

      Lung Foundation Australia Brian Eaton Memorial PhD Scholarship in IPF – closes 10th June 2019

      Lung Foundation Australia Diana Cox PhD Scholarship in IPF – closes 10th June 2019

      Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

      Travel application deadlines

      ATS: 22nd March 2019 (5pm AEST)

      ERS: 31st July 2019 (5pm AEST)

      APSR: 13th September 2019 (5pm AEST)

       

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Watch this space for more award announcements…

      Respirology – Editor’s Choice

      Respirology Issue 24.4 2019

      Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

      Helen E. Jo, Ian Glaspole, Nicole Goh, Peter M.A. Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, Eugene Haydn Walters, Christopher Zappala, Heather Allan, Sacha Macansh, Christopher Grainge, Gregory J. Keir, Andrew Hayen, Douglas Henderson, Sonja Klebe, Stefan B. Heinze, Anne Miller, Hannah C. Rouse, Edwina Duhig, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Samuel R. McCormack, Bernard Ng, David B. Godbolt, Tamera J. Corte

      DOI: 10.1111/resp.13427 

      Distribution of participants in the Australian IPF Registry

       

      A consensus opinion amongst stakeholders as to benefits of obstructive sleep apnoea treatment for cardiovascular health

      Shane A. Landry, Siobhan Banks, Peter A. Cistulli, Garun S. Hamilton, Laure Héraud, Kristina Kairaitis, Steven Lubke, Sutapa Mukherjee, Teanau Roebuck, Joesph Soda, Darren Umbers, Shantha M. W. Rajaratnam, Darren Mansfield.

      DOI: 10.1111/resp.13413

       

      From left to right: Prof Shantha Rajaratnam, Dr Shane Landry, A/Prof Darren Mansfield from Monash University and the Monash Medical Centre in Melbourne, Australia

      Research Project and Survey Requests

      Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

      If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

      We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

      A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

      For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

      If you agree to participate, please follow the link to complete the survey

      http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

      *for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

      Thank you,

      Peter Wark
      Jodie Simpson
      J. Michael Ramsahai
       JamesMichael.Ramsahai@uon.edu.au

       

      Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

      To Members of the Thoracic Society of Australia and New Zealand,

      Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

      The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

      Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

      Thank you for your kind support.

      Yours truly

      Rachel McLellan, Advanced RACP Trainee
      Kwun Fong
      Henry Marshall
      Rayleen Bowman
      Ian Yang

      University of Queensland Thoracic Research Centre at The Prince Charles Hospital
      Metro North Hospital and Health Service | Queensland Government
      Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
      t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

       

       

      New survey about Victorian doctors’ end-of-life decision-making

      Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

      At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

      A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

      If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

       

      Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

      Dear TSANZ Member,

      You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

      The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD

      If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

      We thank you in advance for your participation.

      Sincerely,

      Van Holden, MD
      Mihir Parikh, MD
      Alex Chee, MD
      Adnan Majid, MD

      Division of Thoracic Surgery & Interventional Pulmonology
      Beth Israel Deaconess Medical Center
      Harvard Medical School

      The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 2.03 APRIL 2017

      Research Roundup:

      April 2017

      .
       

      Welcome Message

      Wow, what a conference! I would like to take this opportunity to thank everyone who contributed to making TSANZSRS17 a headline conference. There were many ideas shared and members celebrated. In this Research Roundup we bring to you a full list of the 2017 award winners. But this year of awards is not over yet! Please see below and online at Open Awards to find current opportunities in CF training and research, conference travel, and project support through the Lungs for Life Research Awards. 

      Enjoy the April edition of your research roundup.

      Prof Phil Hansbro

      Chair, Research Sub-Committee

      The following articles will take you to thelimbic.com

      Aussie research win! The American College of Physicians have highlighted an Australian study as one of the most influential in respiratory medicine from 2016. Read More. 

      First-ever pulmonary rehabilitation guidelines for Australia and New Zealand. One key message from the guidelines is that all COPD patients should be offered pulmonary rehabilitation regardless of their disease severity, guideline panel Chair Professor Jennifer Alison told the limbicRead More.

      Hidden population at risk of thunderstorm asthma. Many more people than previously thought are at risk of thunderstorm asthma, particularly people who have hay fever, a survey reveals. Read More.

      Doctor deaths prompt further investigation. NSW Health Minister Brad Hazzard has asked his department to report back within four weeks with advice on how to make hospitals a safer workplace for junior doctors. Read More. 

      Respiratory nurses agree they have a role in advance care planning. But tension still exists about how and when to initiate conversations with patients, Dr Rebecca Disler told conference delegates. Read More. 

      Short on drug options for shortness of breath. Morphine is still the best pharmacological treatment for chronic breathlessness, according to an extensive review of the literature. Read More.

      GPs too passive in approach to COPD. GPs hold back on formerly diagnosing people with COPD and delay offering interventions such as smoking cessation or pulmonary rehabilitation, a survey shows. Read More.

      New hope for people with IPF. Evidence is building for the non-pharmacological management of idiopathic pulmonary fibrosis including ambulatory oxygen and pulmonary rehabilitation, Professor Anne Holland told the conference this afternoon during a plenary session on novel therapies in IPF. Read More. 

      2017 Award Winners

      Presented at the 2017 TSANZ ASM in Canberra

      Thoracic Society Medals

      Laennec Medal – presented to the outgoing TSANZ President, Prof Peter Gibson

      Society Medal – presented to A/Prof Peter Holmes

      50th Anniversary Medal – presented to Prof Jennifer Alison and Prof Richard Ruffin

      President’s Award – presented to Dr Becky Freeman

      Wunderly Oration – delivered by Prof Jennifer Martin

      Fellowships

      TSANZ / National Asthma Council Australia – Asthma and Airways Career Development Fellowship – presented to Dr Adam Collison

      2016 Vertex Adult Cystic Fibrosis  Fellowship – presented to Dr Anna Tai

      Lung Foundation Australia / Boehringer Ingelheim COPD Research Fellowship 2017/2018 – presented to Dr Anna Hudson

      Abstract-linked Awards

      TSANZ Janet Elder Early Career Travel Awards – presented to Dr Luke Garratt and Dr Jade Jaffar

      TSANZ Janet Elder Mid Career Travel Award – presented to Prof Lisa Wood

      TSANZ / Japanese Respiratory Society Early Career Travel Award – presented to Dr Eugene Roscioli

      TSANZ / Boehringer Ingelheim COPD Travel Award – presented to Dr Eskandarain Shaffudin

      Ann Woolcock New Investigator Finalists

      Tim Rosenow, Telethon Kids, University of Western Australia
      Simone Barry, Royal Adelaide Hospital
      Eugene Roscioli, Royal Adelaide Hospital, Lung Research Laboratory
      Thomas Iosifidis, University of Western Australia [Winner]
      Rhiannon Werder, University of Queensland
      Phillipa Southwell, Charles Sturt University

      Research Project Support Awards

      2016 Boehringer Ingelheim COPD Research Award – presented to A/Prof Greg Hodge and Prof Sandra Hodge

      2017 Boehringer Ingelheim COPD Research Award – presented to Dr Maria Sukkar and Dr Jane Bourke

      Maurice Blackburn Grant-in-Aid for Asbestos Research – presented to Prof Steve Mutsaers

      AstraZeneca Grant-in-Aid for Severe Asthma – presented to Dr Fatemeh Moheimani

      TSANZ Robert Pierce Grant-in-Aid for Indigenous Lung Health – presented to Dr Holly Clifford

      Lung Foundation Australia / Ivan Cash Research Grant-in-Aid Award – presented to Dr Yet Hong Khor

      Lung Foundation Australia / Lizotte Family Research Award – presented to Dr Michael Schuliga

      Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research – presented to Prof Peter Middleton

      Australian Cystic Fibrosis Research Trust 2017 Innovation Grant – presented to Dr Jay Horvat, Prof Peter Wark, and Prof Phil Hansbro

      Travel Awards

      TSANZ Peter Phelan Travel Fellowship – presented to Dr Kimberley Wang

      TSANZ Respiratory Nurse Career Development Award for Indigenous Research – presented to Ms Erin Plumb

      Special Interest Group Awards

      • TSANZ Best Poster Prize (supported by Boehringer Ingelheim) – presented to David Chapman
      • Asthma & Allergy (supported by National Asthma Council Australia) – presented to Joy Lee
      • Asthma & Allergy (supported by Asthma Australia) – presented to James Pinkerton
      • OELD/Population Health (supported by Maurice Blackburn ) – presented to Holly Clifford
      • Lung Cancer (supported by Maurice Blackburn) – presented to Koliarne Tong
      • COPD (supported by Boehringer Ingelheim) – presented to Steven Maltby
      • OLIV (supported by Boehringer Ingelheim) – presented to Rebecca Harper
      • Primary Care (supported by Boehringer Ingelheim) – presented to Juliet Foster
      • Respiratory Nurses Oral (supported by Boehringer Ingelheim) – to co-presenters Mary Roberts and Vinita Swami
      • Pulmonary Physiology and Sleep, John Reid Prize (supported by Lung Foundation Australia) – presented to Mahesh Dharmakamara
      • David Serisier Memorial Award 2016 for Translational Research – Respiratory Infectious Disease (supported by Lung Foundation Australia) – presented to Su-Ling Loo
      • Cystic Fibrosis (Supported by Cystic Fibrosis Australia) – presented to Michelle Wood
      • Cell biology/Immunology – Andrew Reid
      • Evidence Based Medicine – presented to Narelle Cox
      • Interventional Pulmonology – presented to Arash Badiei
      • Peter van Asperen Paediatric Award – presented to Ajay Kevat
      • Physiotherapy – presented to Sally Wootton
      • Tobacco Control – presented to Jenifer Liang

      Open Awards

      Vertex Awards

      Vertex Paediatric Cystic Fibrosis Clinical Fellowship

      The TSANZ Vertex Cystic Fibrosis Paediatric Clinical Fellowship supports an articulated training program for advanced trainees who are currently, or who wish to sub-specialize in Paediatric Respiratory Medicine, specifically to conduct the research, diagnosis and management of cystic fibrosis in Australia and New Zealand.

      This is a unique opportunity to secure a fellowship that supports clinic based training in a Paediatric specialty area.

      The fellowship shall be to the value of AUD$50,000 per annum for two years.

      Vertex Adult Cystic Fibrosis Fellowship

      The TSANZ Vertex Adult Cystic Fibrosis Fellowship will support a health practitioner or research scientist working in respiratory medicine who wishes to undertake research into adult cystic fibrosis, accompanied with professional development in adult cystic fibrosis in Australia or New Zealand.

      This is a unique opportunity to secure a fellowship that supports either research and/or clinic based training / professional development in the adult cystic fibrosis specialty area.

      The fellowship shall be to the value of AUD$50,000 per annum for two years.

      Vertex Cystic Fibrosis Research Awards

      To foster ongoing original cystic fibrosis research and its communication internationally.

      The winners of the awards (2) will receive an award up to the value of AUD$7500 each to support their economy class travel, registration and accommodation to present their research at the European Cystic Fibrosis Society Annual Meeting or the North American Cystic Fibrosis Conference.

      Lungs for Life Awards

      Lungs for Life Research Awards

      This Research Award aims to provide seed funding for critical and impactful areas of respiratory research. Preference will be given to research proposals in the priorities areas of early lung development, infection, and lung cancer. Three research proposals will be funded.

      The Research Award value will total $40,000. Funds will be offered as $20,000 from Lungs for Life and must be matched with equal or greater funding from the applicant’s institution.

      Lung Foundation Awards

      Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

      Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

      Watch this space for more award announcements…

      Lungs for Life Grant Bulletin

      The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late April and mid-2017:

      Association for International Cancer Research Grants – 21/04/17
      Project grants of between one and three years to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. Proposals in which a mixture of basic and clinical research is proposed will be considered.

      The Rebecca L. Cooper Medical Research Foundation Al and Val Rosenstrauss Medical Research Fellowship – closes 28/04/17
      The Al and Val Rosenstrauss Research Fellowships are named in honour of the late Al Rosenstrauss OAM and his wife, Val, for their contribution to the work of the Foundation over a period of more than 28 years. Research project must be in one of the nominated areas of medical research that are supported by the Foundation; Brain Sciences, Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, and Vision Sciences. Applicants who have received previous funding, or worked in a laboratory supported by the Foundation, will be favoured.

      The Bioinformatics Peer Prize – closes 30/04/17
      In partnership with the Centre for Systems Genomics at the University of Melbourne, The Australian Regenerative Medicine Institute at Monash University & Melbourne Bioinformatics, Thinkable is excited to launch the inaugural ‘Peer Prize’ for bioinformatics. The objective is to accelerate wider knowledge exchange & drive multi-disciplinary collaboration with the latest bioinformatics research from around the world, while celebrating the most exciting new discoveries made in the field as voted by peers.

      Sylvia and Charles Viertel Charitable Foundation Clinical Investigatorships – closes 30/04/17
      To stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment.

      Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship – closes 30/04/17
      Providing salary and project grant support for outstanding medical researchers.

      Bill & Melinda Gates Foundation Grand Challenges Explorations Round 19 – closes 11/05/17
      Early-stage innovative research projects from a range of disciplines and regions.

      Winston Churchill Memorial Trust Fellowship – closes 15/05/17
      To provide an opportunity for Australians to travel overseas (for 4 – 6 weeks) to conduct research in their chosen field that is not readily available in Australia.

      The Prince Charles Hospital Foundation Experienced Researcher Project Grants – closes 20/05/17
      To support strategic, world-class, sophisticated research on the Foundation’s campus or in significant partnership with this campus in the priority areas of: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

      Australian Institute of Policy and Science – CSL Florey Medal – closes 28/05/17
      Award for an Australian biomedical researcher with significant achievements in biomedical science and/or human health advancement for research conducted primarily in Australia. Winners are expected to attend a presentation ceremony in Canberra in November.

      The NVIDIA Foundation Compute the Cure Cancer Research Grants – closes 28/05/17
      To advance the fight against cancer. Will fund projects that use computational omics to dramatically impact the battle against cancer and reduce the time it takes for research outcomes to be used effectively in a clinical environment.

      Australian Institute of Policy and Science – CSL Young Florey Medal – closes 06/06/17
      Award for an Australian biomedical researcher with significant early career achievements in biomedical science and/or human health advancement. Selection Criteria: Excellence in research achievement in the biomedical science and/or human health advancement; and Excellence and passion in communication and community engagement to promote understanding and engagement in science.

      Wellcome Trust Pathfinder Awards – closes 20/06/17
      The diagnosis, prevention and treatment of orphan and neglected diseases that present an unmet medical need. Seeking to fund pilot studies to develop assets and de-risk future development.

      Australian Cancer Research Foundation (ACRF) Cancer Research Grants – closes 23/06/17
      Seeks to support all aspects of cancer research and control including but not limited to: cell or molecular biology, epidemiology, early detection, prevention and drug development. Focused on seed funding; primarily providing capital grants for major equipment, and the establishment of capital works and facilities. Collaborative projects between institutions are encouraged.

      John T Reid Charitable Trusts – closes 28/06/17
      The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

      The Sir Robert Menzies Memorial Research Scholarship in the Allied Health Sciences – closes 30/06/17
      The purpose of the scholarship is to try to improve the health of Australians by supporting an outstanding applicant from one of the non‐medical allied health disciplines, or from an applicant who is working directly in applied clinical research.

      The John Burge Trust – closes 30/06/17
      The John Burge Trust was established by the late John Burge to assist people with tuberculosis and support work towards the prevention and cure of the disease. This can include: educational programs for health workers; aid and help for tuberculosis sufferers and who by reason of the disease are disabled; medication; research.

      Shepherd Foundation Research Grants – closes 01/07/17 and 15/09/17
      For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

      Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
      Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

      The Alan Westcare Project Grant – closes 31/07/17
      The Alan King Westcare Project Grant is a 12 month $50,000 grant to available to laboratory, clinical and epidemiological research into the cause, diagnosis, prevention and treatment of respiratory infections such as tuberculosis.

      CSL Centenary Fellowships 2017 – closes 31/07/17
      To foster excellence in Australian medical research by supporting mid-career Australian scientists to pursue world class medical research. The fellowship provides for a full-time salary (generally equivalent to a Senior Research Fellow C1 level) plus research costs and/or a post-doctoral research assistant. The breakdown is determined by the Fellow, in conjunction with the employing institution at the commencement of the Fellowship. The fellowships are primarily awarded for discovery and translational research with a focus on rare and serious diseases, immunology, and inflammation. However, those who meet the eligibility are strongly encouraged to submit an application for their medical research project.

      Government of Western Australia – 2017 Healthway Intervention Research Grants – closing date TBA
      Intervention Research Grants will fund applications that demonstrate a clear pathway to a health promotion program or intervention in WA, including policy interventions. Applicants are required to focus on at least one of Healthway’s priority areas of tobacco smoking control, reducing harm from alcohol, good nutrition promotion, physical activity promotion (including reducing sedentary behaviour), mental health promotion, skin cancer prevention, reducing harm from illicit drugs and Aboriginal health. Applications in other areas of health promotion will not be considered.

      Rolling Grants

      Advance Queensland Founders’ Fellowships – closes 12/05/17 (quarter one round)
      To support entrepreneurial scientists, researchers and clinicians to take 12 months away from their normal job to develop their early stage novel and innovative ideas with commercialisation prospects into new products, processes or services.

      Boehringer Ingelheim Fonds Travel Grants
      Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

      Baxalta Bioscience Grants – Medical Education & Fellowship Grants
      Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

      Coopers Brewery Foundation – current round closes 01/08/2017
      Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

      The Balnaves Foundation
      The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

       

      Respirology

      Respirology Issue 22.3

      Association between asthma control and asthma cost: Results from a longitudinal study in a primary care setting

      By Nguyen et al. (resp.12930/ RES-16-407.R2)

       

      Singhealth Duke-NUS Research team members from Canada and Singapore. Left to right:Lye Weng Kit, Dr Ngiap C. Tan, Dr. Nivedita V. Nadkarni, Usha Sankari, Dr Hai V. Nguyen and Shweta Mital.

       

      YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia

      By Spoorenberg et al. (resp12924/RES-16-449.R1)

       

      CAP study group members from St Antonius Hospital in Nieuwegein, The Netherlands.

      Left to right: Willem Jan Bos, Simone Spoorenberg, Stefan Vestjens and Jan Grutters.

       

      Respirology Issue 22.4

      Home-based telerehabilitation via real-time videoconferencing improves endurance exercise capacity in patients with COPD: The randomized controlled TeleR Study

      LING LING Y. TSAI, RENAE J. MCNAMARA, CHLOE MODDEL, JENNIFER A. ALISON, DAVID K. MCKENZIE AND ZOE J. MCKEOUGH   

      (DOI: 10.1111/resp.12966)

       

      The respiratory telerehabilitation (TeleR) trial team from Sydney, Australia

       

      Nasal lavage, blood or sputum: Which is best for phenotyping asthma?

      CAMYLA F. DE FARIAS, MARIA M.F. AMORIM, MICHEL DRACOULAKIS, LILIAN B. CAETANO, ILKA L. SANTORO AND ANA L.G. FERNANDES

      (DOI: 10.1111/resp.12958)

       

      The Asthma Group EPM-Unifesp from São Paulo, Brazil. Left to right: Danilla Assad Fernandes, Lilian Ballini Caetano, Michel Dracoulakis, Patricia Bueno Fernandes, Fabiana Stanzani, Camyla Fernandes, Maria Amélia Carvalho Santos, Ana Luisa Godoy Fernandes, Maria Marta Amorim.

      Australasian Clinical Tuberculosis Network (ACTnet)

      The Australasian Clinical Tuberculosis Network (ACTnet) is a collaborative clinical research group spanning Australia and New Zealand. Following the successful model of the European “TBnet” collaboration (www.tb-net.org), ACTnet will engage clinicians and researchers across the two countries to conduct high-quality research of national and international significance. It will provide a platform for individual investigators, within infectious disease, respiratory, public health and other disciplines, to propose and implement multi-centre studies and laboratory collaborations.

      ACTnet aims to promote basic science, clinical and public health research into TB in Australia and New Zealand. We will be working in partnership to create the knowledge required to eliminate TB in Australia, New Zealand and beyond.

      We are inviting TSANZ members to join our network. There are a variety of ways you can contribute to the growth of this network but becoming a member is the first step.  Please see our website www.actnet.org.au  further details and if interested click on the ‘Become a member’ sign up box on the home page.

      Alternatively you can send an email to elyse.guevara-rattray@sydney.edu.au the ACTnet Network Officer. ACTnet is supported by ARC, TSANZ, ASID and TBForum.

      Research Project and Survey Requests 

      Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

      Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

      https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

      If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

      This study has been approved by the Austin Health Human Research Ethics Committee.

       

      Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

      If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

      An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

      If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

      A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
      Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

      Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
      Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

       

      Paediatric PFT needs assessment

      We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

      The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

      Survey

      Thank you for your time.

      Nitin Kapur, Paediatric SIG Convenor

      on behalf of 

      Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

      Graham Hall, BSc PhD
      Jessica Pittman, MD MPH
      Padmaja Subbarao, MD MSc FRCP
      Claudia Calogero, MD
      Stephanie Davis, MD
      Margaret Rosenfeld, MD MPH

       
       

       

       

       

       
       
       
       
       
       
       
       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 2.02 MARCH 2017

      Research Roundup:

      March 2017

      .
       

      Welcome Message

      March is shaping up to be jam-packed with research. The ASM is just over two weeks away and on top of all the novel research which we will be hearing about, there are many additional workshops and post-graduate courses which are very exciting for both clinical and basic science researchers. Special mention also goes to the Early Career Researcher Networking Session which will again take place at the TSANZ ASM and all students and early post-docs are encouraged to attend.

      Please be reminded that applications are closing soon for the Dust Diseases grants.

      I would like to take this opportunity to let our members know that the Research Committee is still working through the many applications we received for the 2017 awards. Due to the increasing TSANZ Awards portfolio, the review process is taking longer than expected. Applicants will soon be notified of their award outcomes. 

      There is much more information and opportunities for you to explore below. Please enjoy your March Research Roundup,

      Prof Phil Hansbro

      Chair, Research Sub-Committee

      The following articles will take you to thelimbic.com

      No breathing space at the TSANZSRS conference. A shorter program this year doesn’t mean delegates at the combined annual scientific meetings of the Australia and New Zealand Society of Respiratory Science and the Thoracic Society of Australia and New Zealand will be getting shortchanged. Read More.

      Five-fold variation in specialists’ fees. Experts are calling for more transparency around specialist fees after finding huge variations in out-of-pocket costs and bulk billing rates within and between specialties and geographic locations. But respiratory physicians had one of the lowest out-of-pocket costs for patients. Read More.

      COPD-X update. The evidence for the benefits of pulmonary rehabilitation has been strengthened in the latest update of the Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease (COPD-X). Read More.

      Inhaler techniques haven’t improved in 40 years. A large study of almost 3,000 patients observed using their inhalers by GPs or respiratory physicians, found more than half were not using their devices correctly – regardless of the type of device. Read More.

      “Don’t push yourself” mantra debunked in ILD. Clinicians should strongly encourage patients with interstitial lung disease to attend pulmonary rehabilitation, new research shows. Read More.

      Cytology is sufficient to diagnose most mesothelioma cases. A review of over 2,000 cases of mesothelioma in WA since 1962 has shown a cytological diagnosis of the disease subtype is sufficient. Read More.

      Apply caution to latest vitamin D study. Experts have thrown cold water over the findings of a recent meta-analysis that concluded the prevention of acute respiratory tract infection was a “major new indication” for vitamin D supplementation. Read More.

      Open Awards

       

       

      Lung Foundation Awards

      Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

      Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

       

      Watch this space for more award announcements…

      TSANZSRS Early Career Researcher Networking Session

      Sunday 26th March, 2017, 5:00 – 6:30pm

      For those of you who are Honours, Masters or PhD students, or Post-Docs starting out their careers – this event is for you. This session allows students, post-docs and other early career researchers to come together for an interactive session to get to know your colleagues. 

      This will be an opportunity to hear from Dr Kristin Carson and Prof Phil Hansboro for career advice and information, followed by a chance to get to know other ECRs and researchers from around Australia and New Zealand over drinks and canapés. 

      Please RSVP for this event by 20th March, 2017 by clicking here

       

      Australasian Clinical Tuberculosis Network (ACTnet)

      We welcome the newly formed Australasian Clinical Tuberculosis Network (ACTnet). ACTnet is a collaborative clinical research group for Australia and New Zealand. Following the successful model of the European “TBnet” collaboration, ACTnet will engage clinicians and researchers to conduct high-quality research of national and international significance. It will provide a platform for individual investigators, within infectious disease, respiratory, public health and other disciplines, to propose and implement multi-centre studies and laboratory collaborations. In particular, it will develop evidence to advance the goal of TB elimination in the two countries.

      ACTnet will facilitate research, obtaining funding and supporting research activities. The organisation will have complementary roles, and work alongside other peak clinical and research bodies in Australia and New Zealand to strengthen TB control through research.

      ACTnet will be officially launched by Dr Greg Fox at the TSANZ ASM on Monday 27th of March at the end of the Advances in Tuberculosis SIG meeting 8.30-10am. We welcome attendees to join us for light refreshments afterward and to join our network to receive updates www.actnet.org.au or interact with us via twitter @actnet_tb.

      Respirology

      New Release

      Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report (GOLD Executive Summary)

      http://onlinelibrary.wiley.com/doi/10.1111/resp.13012/full

      Published jointly in the American Journal of Respiratory and Critical Care Medicine, the European Respiratory Journal and the Archivos de Bronconeumologia.

       

      Lungs for Life Grant Bulletin

      The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late March and mid-2017:

      Ramaciotti Foundation’s (Perpetual Trustees) Biomedical Research Award – closes 17/03/17
      Presented every two years to a group or individual undertaking biomedical research within universities, public hospitals, medical research institutes or other similar organisations. The award funds projects including personnel, equipment, major infrastructure improvements or new laboratories that help an existing, well-funded program of research or enable a major new program to begin. Traditionally, it funds a need that would not attract funding elsewhere.

      Channel 7 Children’s Research Foundation Grants – closes 21/03/17
      Supports health, educational or social research to encourage and advance investigation into the cause, prevention, diagnosis and treatment of any condition that may affect the general health, education or welfare of children in South Australia and the Northern Territory.

      World of Children Health Award (2017) – closes 01/04/17
      The Health Award recognises an individual who has made a significant contribution to children in the fields of health, medicine or the sciences.

      Cancer Research Institute CRI Irvington Postdoctoral Fellowship Program – closes 01/04/17
      Supports qualified young scientists at leading universities and research centres around the world who wish to receive training in cancer immunology. An eligible project must be immunology with direct relevance to solving the cancer problem.

      L’Oreal Australia and New Zealand for Women in Science Fellowships – 2017 – closes 03/04/17 
      For early career women scientists to consolidate their careers and rise to leadership positions in science. The Fellowships are awarded to women who have shown scientific excellence in their career with an appropriate research plan that will be assisted by the one-year Fellowship.

      Association for International Cancer Research Grants – 21/04/17
      Project grants of between one and three years to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. Proposals in which a mixture of basic and clinical research is proposed will be considered.

      The Rebecca L. Cooper Medical Research Foundation Al and Val Rosenstrauss Medical Research Fellowship – closes 28/04/17
      The Al and Val Rosenstrauss Research Fellowships are named in honour of the late Al Rosenstrauss OAM and his wife, Val, for their contribution to the work of the Foundation over a period of more than 28 years. Research project must be in one of the nominated areas of medical research that are supported by the Foundation; Brain Sciences, Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, and Vision Sciences. Applicants who have received previous funding, or worked in a laboratory supported by the Foundation, will be favoured.

      Sylvia and Charles Viertel Charitable Foundation Clinical Investigatorships – closes 30/04/17
      To stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment.

      Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship – closes 30/04/17
      Providing salary and project grant support for outstanding medical researchers.

      Bill & Melinda Gates Foundation Grand Challenges Explorations Round 19 – closes 11/05/17
      Early-stage innovative research projects from a range of disciplines and regions.

      Winston Churchill Memorial Trust Fellowship – closes 15/05/17
      To provide an opportunity for Australians to travel overseas (for 4 – 6 weeks) to conduct research in their chosen field that is not readily available in Australia.

      The Prince Charles Hospital Foundation Experienced Researcher Project Grants – closes 20/05/17
      To support strategic, world-class, sophisticated research on the Foundation’s campus or in significant partnership with this campus in the priority areas of: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

      Australian Institute of Policy and Science – CSL Florey Medal – closes 28/05/17
      Award for an Australian biomedical researcher with significant achievements in biomedical science and/or human health advancement for research conducted primarily in Australia. Winners are expected to attend a presentation ceremony in Canberra in November.

      The NVIDIA Foundation Compute the Cure Cancer Research Grants – closes 28/05/17
      To advance the fight against cancer. Will fund projects that use computational omics to dramatically impact the battle against cancer and reduce the time it takes for research outcomes to be used effectively in a clinical environment.

      Australian Institute of Policy and Science – CSL Young Florey Medal – closes 06/06/17
      Award for an Australian biomedical researcher with significant early career achievements in biomedical science and/or human health advancement. Selection Criteria: Excellence in research achievement in the biomedical science and/or human health advancement; and Excellence and passion in communication and community engagement to promote understanding and engagement in science.

      Wellcome Trust Pathfinder Awards – closes 20/06/17
      The diagnosis, prevention and treatment of orphan and neglected diseases that present an unmet medical need. Seeking to fund pilot studies to develop assets and de-risk future development.

      Australian Cancer Research Foundation (ACRF) Cancer Research Grants – expected close 24/06/17
      Seeks to support all aspects of cancer research and control including but not limited to: cell or molecular biology, epidemiology, early detection, prevention and drug development. Focused on seed funding; primarily providing capital grants for major equipment, and the establishment of capital works and facilities. Collaborative projects between institutions are encouraged.

      John T Reid Charitable Trusts – closes 28/06/17
      The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

      The Sir Robert Menzies Memorial Research Scholarship in the Allied Health Sciences – closes 30/06/17
      The purpose of the scholarship is to try to improve the health of Australians by supporting an outstanding applicant from one of the non‐medical allied health disciplines, or from an applicant who is working directly in applied clinical research.

      The John Burge Trust – closes 30/06/17
      The John Burge Trust was established by the late John Burge to assist people with tuberculosis and support work towards the prevention and cure of the disease. This can include: educational programs for health workers; aid and help for tuberculosis sufferers and who by reason of the disease are disabled; medication; research.

      Shepherd Foundation Research Grants – closes 01/07/17 and 15/09/17
      For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

      Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
      Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

      CSL Centenary Fellowships 2017 – closes 31/07/17
      To foster excellence in Australian medical research by supporting mid-career Australian scientists to pursue world class medical research. The fellowship provides for a full-time salary (generally equivalent to a Senior Research Fellow C1 level) plus research costs and/or a post-doctoral research assistant. The breakdown is determined by the Fellow, in conjunction with the employing institution at the commencement of the Fellowship. The fellowships are primarily awarded for discovery and translational research with a focus on rare and serious diseases, immunology, and inflammation. However, those who meet the eligibility are strongly encouraged to submit an application for their medical research project.

      Government of Western Australia – 2017 Healthway Intervention Research Grants – closing date TBA
      Intervention Research Grants will fund applications that demonstrate a clear pathway to a health promotion program or intervention in WA, including policy interventions. Applicants are required to focus on at least one of Healthway’s priority areas of tobacco smoking control, reducing harm from alcohol, good nutrition promotion, physical activity promotion (including reducing sedentary behaviour), mental health promotion, skin cancer prevention, reducing harm from illicit drugs and Aboriginal health. Applications in other areas of health promotion will not be considered.

      Rolling Grants

      Advance Queensland Founders’ Fellowships – closes 12/05/17 (quarter one round)
      To support entrepreneurial scientists, researchers and clinicians to take 12 months away from their normal job to develop their early stage novel and innovative ideas with commercialisation prospects into new products, processes or services.

      Boehringer Ingelheim Fonds Travel Grants
      Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

      Baxalta Bioscience Grants – Medical Education & Fellowship Grants
      Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

      Coopers Brewery Foundation
      Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

      The Balnaves Foundation
      The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

       

       

      Research Project and Survey Requests

      Australasian Lung Cancer Trials Group 16/002 Fear of Cancer Recurrence

      My name is Dr Peey Sei Kok, a medical oncologist and research fellow for the Australasian Lung Cancer Trials Group at the NHMRC Clinical Trials Centre. I am currently working on an NHMRC project grant submission on behalf of A/Prof Sue-Anne McLachlan, medical oncologist for a trial being developed by a collaboration between the ALTG and Psycho-oncology Co-operative Research Group (PoCOG). I am seeking input and support from thoracic surgeons and respiratory physicians for this prospective longitudinal cohort study which aims to assess the prevalence and nature of Fear of Cancer Recurrence in patients with resected stage 1-3A NSCLC.

      I would be very pleased to receive your expressions of interest through the link provided below. To finalise the grant submission on time, I would be grateful if you would submit your responses to this short survey by 10th of March 2017.

      EXPRESSIONS OF INTEREST for ALTG 16/002 Fear of Cancer Recurrence (FCR)

      This will be the first large scale, longitudinal study of FCR in lung cancer and an important contribution to the research for survivorship of lung cancer. We are submitting an NHMRC project grant application (seeking funding from 2018) and need to ensure we have confirmed support from investigators for this important initiative.

      https://www.surveymonkey.com/r/2TKFYCG 

      For further information please contact Peey-Sei Kok, Research Fellow at peey-sei.kok@ctc.usyd.edu.au


       

      Reminder: Survey invitation for Nurses and Allied Health on advance care planning in COPD

      Dear Colleague

      Our research team is conducting a survey to understand Palliative Care Nurses, Respiratory Nurses, and Allied Health Professionals that work in respiratory care’s knowledge and practice around advance care planning in patients with COPD. From the results of this study we hope to develop educational resources to assist health professionals when caring for this patient group.

      We invite you to participate in a survey, that should take only 10-15 minutes to complete. Several disciplines are represented in the overall survey, however you will be directed to only those questions relevant to your discipline.

      Ethics approval has been granted for this study from the University of Sydney. All responses will be anonymous and confidential. No personal information that could identify you is being collected and your email address will not be linked to your survey response. Your consent to participate in this study is implied by completing the survey.

      Further information about this research study is provided in the enclosed document [DOWNLOAD]. If you have any questions regarding this research, please do not hesitate to contact Dr Rebecca Disler directly. Thank you in advance for participating.

      Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:

      https://www.surveymonkey.com/r/ACPHealthProf

      Kind regards

      Dr Rebecca Disler | Senior Lecturer in Chronic Disease | The University of Sydney
      Email: rebecca.disler@sydney.edu.au  | Tel: 0406 876 587

      Dr Natasha Smallwood | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
      A/Prof Louis Irving | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
      Prof David Currow | Palliative Care Physician Flinders University | Adelaide

      STUDENT DECLARATION
      Yuxiu Cui will be analysing the anonymous study results as the basis for her degree of Bachelor of Advanced Nursing (Honours) at The University of Sydney. This will take place under the supervision of Dr Rebecca Disler.

       

       
       

       

       

       

       
       
       
       
       
       
       
       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 2.01 FEBRUARY 2017

      Research Roundup:

      February 2017

      .
       

      Welcome Message

      Welcome to 2017 and our first Research Roundup of the new year.

      As I emerge briefly from my grant writing, I would like to let everyone know that icare dust diseases care have opened their award round for 2017. They will offer Discovery grants, Translational research grants, and Clinical trial infrastructure support grants. Please see below for more details.

      I’d also like to introduce a new feature to the Research Roundup, the Respirology Editor’s Choice. In it you will find links to open access articles from each monthly publication, accompanied with photos of the authors – many of which are TSANZ members.

      Lastly, for those of you who have en bloc membership with ERS, the ERS Gold Medalgrants of €50,000 are now available. This award goes to researchers who have made an outstanding contribution in COPD, Asthma, or IPF, and are currently pursuing an active research project in these fields.

      I wish you well in your grant writing and preparation for the ASM. 

      Enjoy your February Research Roundup,

      Prof Phil Hansbro

      Chair, Research Sub-Committee

      The following articles will take you to thelimbic.com

      A watershed moment for COPD research. A genome-wide association study of almost 50,000 people has uncovered 68 high priority genes as targets for future COPD drug development. We find out more from co-author and respiratory physician Professor Alan James, from the University of Western Australia. Read more.

      Respiratory infection an ‘under-appreciated’ MI risk. People have a 17-fold increased risk of acute MI within the first seven days of experiencing lower respiratory infection symptoms an Australian study shows. Read more.

      + Spirometry report highlights access issues. A new report into the use of spirometry in the diagnosis and management of chronic airways disease has highlighted “huge barriers” to access. Read More.

      $1 million response to thunderstorm asthma. In response to the thunderstorm asthma event in Melbourne and Geelong last November, the Victorian Government has pledged $1 million to better understand and help predict the rare phenomenon. Read more.

      Lung cancer remains #1 cause of cancer deaths. A report from the Australian Institute of Health and Welfare confirms that lung cancer remains Australia’s leading cause of cancer deaths – with over 9,000 deaths from the disease anticipated in 2017. Read more.

      Open Awards

       

      Watch this space for more award announcements…

      Respirology Editor’s Choice

      Respirology Issue 22.2

      Infant lung function predicts asthma persistence and remission in young adults

      By Owens et al. (resp.12901/ RES-16-007.R2)

       

      Dr Louisa Owens with Infant Lung Function testing equipment

       

      Characteristics, incidence and outcome of patients admitted to intensive care because of pulmonary embolism

      By Winterton et al. (resp12881/RES-15-779.R2)

      Incidence of pulmonary embolism over time relative to intensive care unit admissions (top) and relative to the overall Australia and New Zealand population (bottom).

       

      Respirology Issue 22.1

      Ecological study on solid fuel use and pneumonia in young children: A worldwide association

      By Accinelli et al. (resp.12865/ RES-16-237.R1)

      Illustrative example of indoor biomass pollution and the favourable impact of the installation of a non-polluting stove in Peru.

      Malignant pleural fluid from mesothelioma has potent biological activities

      By Lee et al. (resp12874/RES-16-044.R1)

      From left to right: Prof Gary Lee, Dr Su Lyn Leong, Hui Min Cheah, Dr Sally Lansley and Prof Jenette Creaney at the Harry Perkins Instituteof Medical Research in Perth, Western Australia.

      Lungs for Life Grant Bulletin

      The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late March and mid-2017:

      Ramaciotti Foundation’s (Perpetual Trustees) Biomedical Research Award – closes 17/03/17
      Presented every two years to a group or individual undertaking biomedical research within universities, public hospitals, medical research institutes or other similar organisations. The award funds projects including personnel, equipment, major infrastructure improvements or new laboratories that help an existing, well-funded program of research or enable a major new program to begin. Traditionally, it funds a need that would not attract funding elsewhere.

      Channel 7 Children’s Research Foundation Grants – closes 21/03/17
      Supports health, educational or social research to encourage and advance investigation into the cause, prevention, diagnosis and treatment of any condition that may affect the general health, education or welfare of children in South Australia and the Northern Territory.

      World of Children Health Award (2017) – closes 01/04/17
      The Health Award recognises an individual who has made a significant contribution to children in the fields of health, medicine or the sciences.

      L’Oreal Australia and New Zealand for Women in Science Fellowships – 2017 – closes 03/04/17 
      For early career women scientists to consolidate their careers and rise to leadership positions in science. The Fellowships are awarded to women who have shown scientific excellence in their career with an appropriate research plan that will be assisted by the one-year Fellowship.

      Wellcome Trust Technology Transfer Translation Awards – closes 14/04/17
      Translation Awards aim to bridge the funding gap in the commercialisation of new technologies in the biomedical area. Current highlight area is Restoring the Body; however projects covering any aspect of technology development from a range of disciplines – including physical, computational and life sciences – will be considered.

      The Rebecca L. Cooper Medical Research Foundation Al and Val Rosenstrauss Medical Research Fellowship – closes 28/04/17
      The Al and Val Rosenstrauss Research Fellowships are named in honour of the late Al Rosenstrauss OAM and his wife, Val, for their contribution to the work of the Foundation over a period of more than 28 years. Research project must be in one of the nominated areas of medical research that are supported by the Foundation; Brain Sciences, Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, and Vision Sciences. Applicants who have received previous funding, or worked in a laboratory supported by the Foundation, will be favoured.

      Sylvia and Charles Viertel Charitable Foundation Clinical Investigatorships – closes 30/04/17
      To stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment.

      Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship – closes 30/04/17
      Providing salary and project grant support for outstanding medical researchers.

      Bill & Melinda Gates Foundation Grand Challenges Explorations Round 19 – closes 11/05/17
      Early-stage innovative research projects from a range of disciplines and regions.

      Winston Churchill Memorial Trust Fellowship – closes 15/05/17
      To provide an opportunity for Australians to travel overseas (for 4 – 6 weeks) to conduct research in their chosen field that is not readily available in Australia.

      The Prince Charles Hospital Foundation Experienced Researcher Project Grants – closes 20/05/17
      To support strategic, world-class, sophisticated research on the Foundation’s campus or in significant partnership with this campus in the priority areas of: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

      Australian Institute of Policy and Science – CSL Florey Medal – closes 28/05/17
      Award for an Australian biomedical researcher with significant achievements in biomedical science and/or human health advancement for research conducted primarily in Australia. Winners are expected to attend a presentation ceremony in Canberra in November.

      The NVIDIA Foundation Compute the Cure Cancer Research Grants – closes 28/05/17
      To advance the fight against cancer. Will fund projects that use computational omics to dramatically impact the battle against cancer and reduce the time it takes for research outcomes to be used effectively in a clinical environment.

      Australian Institute of Policy and Science – CSL Young Florey Medal – closes 06/06/17
      Award for an Australian biomedical researcher with significant early career achievements in biomedical science and/or human health advancement. Selection Criteria: Excellence in research achievement in the biomedical science and/or human health advancement; and Excellence and passion in communication and community engagement to promote understanding and engagement in science.

      John T Reid Charitable Trusts – closes 28/06/17
      The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

      Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
      Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

       

      Research Project and Survey Requests

      Reminder: Survey invitation for Nurses and Allied Health on advance care planning in COPD

      Dear Colleague

      Our research team is conducting a survey to understand Palliative Care Nurses, Respiratory Nurses, and Allied Health Professionals that work in respiratory care’s knowledge and practice around advance care planning in patients with COPD. From the results of this study we hope to develop educational resources to assist health professionals when caring for this patient group.

      We invite you to participate in a survey, that should take only 10-15 minutes to complete. Several disciplines are represented in the overall survey, however you will be directed to only those questions relevant to your discipline.

      Ethics approval has been granted for this study from the University of Sydney. All responses will be anonymous and confidential. No personal information that could identify you is being collected and your email address will not be linked to your survey response. Your consent to participate in this study is implied by completing the survey.

      Further information about this research study is provided in the enclosed document [DOWNLOAD]. If you have any questions regarding this research, please do not hesitate to contact Dr Rebecca Disler directly. Thank you in advance for participating.

      Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:   https://www.surveymonkey.com/r/ACPHealthProf

      Kind regards

      Dr Rebecca Disler | Senior Lecturer in Chronic Disease | The University of Sydney
      Email: rebecca.disler@sydney.edu.au  | Tel: 0406 876 587

      Dr Natasha Smallwood | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
      A/Prof Louis Irving | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
      Prof David Currow | Palliative Care Physician Flinders University | Adelaide

      STUDENT DECLARATION
      Yuxiu Cui will be analysing the anonymous study results as the basis for her degree of Bachelor of Advanced Nursing (Honours) at The University of Sydney. This will take place under the supervision of Dr Rebecca Disler.

       

      Acceptability and Perceived Benefit of Prehabilitation amongst Thoracic surgeons throughout Australia

      Dear TSANZ members

      This survey is being conducted to determine the Acceptability and Perceived Benefit of Prehabilitation amongst Thoracic Surgeons throughout Australia. It is part of a larger research project looking at the benefits of prehabilitation for individuals having lung cancer surgery in Australia.

      This survey is open to thoracic surgeons currently practicing in Australia and New Zealand.

      Your help in completing this survey is greatly appreciated. It is hoped that the results of this survey will assist the direction of future research into exercise interventions for patients with lung cancer.

      It is anticipated this survey will take approximately 10 – 15 minutes to complete. Responses to this survey are anonymous and will remain confidential. All responses are voluntary. Completion of the survey will indicate your consent to participate. Please follow the link below to complete the survey online.

      https://www.surveymonkey.com/r/PREHAB

      For further information or assistance with completing this survey please contact Anna Shukla (Senior Cardiorespiratory Physiotherapist – St Vincent’s Hospital, Melbourne):

      Email: anna.shukla@svha.org.au

      This research has been approved by the School Of Health Sciences Human Research Ethics Advisory group (Ethics I.D 1646932) at the University of Melbourne

       
       

       
       

       

       

       

       
       
       
       
       
       
       
       
       

      .

      VOLUME 7.06 – JULY 2022

      VOLUME 1.04 JUNE 2016

      Research Roundup:

      June 2016

      .
       

      Welcome Message

      Welcome to the fourth edition of the TSANZ Research Round Up and a special Call for Action from the President.

      The TSANZ mission is to lead, support and enable all health workers and researchers who aim to prevent, cure and relieve disability caused by lung disease.

      You are part of the Peak Body representing all health professionals working in all fields of respiratory health. The collective voice of our membership base of 1400+ individuals from a wide range of health and research disciplines can produce a powerful message. We are aware that respiratory health has long been neglected in research and health care priority setting, but the greater community is not. More than 1 in 4 Australians are now affected by chronic lung disease.

      This month’s Research Roundup again features our collaborative research project with LFA; Lungs for Life – breathing life into respiratory research. We need our members to take ownership of this initiative by contributing their ideas to help prioritise research areas; and we need your help to engage your networks to drive support for the future of respiratory medicine. Please support Lungs for Life and respiratory research by:

      Enjoy your June Research Roundup,

      Peter Gibson

      The following articles will take you to www.thelimbic.com

      the limbic is a free, independent news site for respiratory health professionals that covers the latest in clinical research and medico-political news.

      Call to revisit COPD guidelines. A leading Australian thoracic specialist and researcher has called for a revision of current COPD criteria to include cough and sputum as red flags for the disease. Read More. 

      Looking back for the future. In our latest Holy Grail we speak to recent recipient of the Lung Foundation Australia / Boehringer Ingelheim COPD Fellowship Dr Christian Osadnik about his research looking at ways to optimise rehabilitation for patients who experience acute exacerbations of chronic obstructive pulmonary disease. Read More. 

      Unravelling the chaos of ACOS. Identifying ‘treatable traits’ is more useful than debating the validity of the diagnosis in patients with asthma-COPD overlap syndrome, TSANZ President Professor Peter Gibson has told delegates attending the American Thoracic Society conference here in San Francisco. Read more.

      Unprecedented cough suppression. A new drug targeting receptors in the vagus nerve provides unprecedented control over refractory chronic cough, but patients can be slow to acknowledge the benefit. Read More.

      ‘Astonishing’ says Professor. A large study adds to a growing body of evidence linking childhood asthma to the development of COPD in early adulthood. Read More.

      COPD highlights from 2015. Last year saw a plethora of COPD research hit the journals but what were the significant findings that could change practice as we know it? Read more.

      If you have any issues accessing the limbic please contact editor@thelimbic.com

      Lungs for Life

       

      The funding for respiratory research in Australia is disproportionately low compared to the national health burden it causes. Whilst respiratory disease affects 1 in 10 Australians, it receives only 7.5% of government research funding. The Thoracic Society of Australia and New Zealand and Lung Foundation Australia have joined forces in a new strategic research initiative called Lungs for Life.

      Research Priority Areas Survey

      The Management Committee of Lungs for Life is now asking all members to help with the development of a detailed research and fundraising plan by seeking members views on ideas for priority respiratory research areas. Please help the Lungs for Life team by giving your feedback at: https://www.surveymonkey.com/r/SPTFCLT 

      Closing date: 6 June 2016

       

       

      Reduce your taxable income by making a donation!

      With the end of the financial year approaching, now is the best time to donate!  A donation before the end of the financial year not only supports the initiatives of TSANZ to improve lung health, but also reduces your taxable income. 

      As a health promotion charity and an endorsed deductible gift recipient (DGR), your donation to TSANZ is claimable as tax deduction if the value of your donation is over AU$2 and you are an Australia tax resident. 

      TSANZ/LFA Lungs for Life Research Fund: https://www.thoracic.org.au/information-public/lungs-for-life

      Please e-mail details of the EFT payment and your contact details to TSANZfinance@thoracic.org.au so a receipt can be sent to you.

      Cycle to support Lungs for Life!

       

      The money you raise by taking part in this exciting and fun filled event will allow Lung Foundation Australia and TSANZ to fund vital research so that we can improve lives today and find the cures for tomorrow

      Medical Research Future Fund Consultation

      Medical Research Future Fund consultation for the development of the Australian Medical Research and Innovation Strategy and related Priorities

      Under the Medical Research Future Fund  (MRFF) Act 2015, the Australian Medical Research Advisory Board  (AMRAB) is tasked with determining the Australian Medical Research and Innovation Strategy and related Priorities for disbursement of funding. The Strategy is determined every five years and the Priorities every two years.

      The Advisory Board is currently accepting written submissions from those who deliver, use or stand to benefit from health services and health and medical research regarding an appropriate focus for the Strategy, and the initial round of Priorities.

      The Advisory Board will be accepting written submissions until the 6th of June 2016

      Please visit the Department of Health Consultation Hub to provide your views.

       

      Research Position Opportunities

      Looking for employment opportunities? Need to recruit someone? We can help.

      We regularly post vacant research positions on our website so check in frequently if you are looking for change.

      Please be advised – the CSL Centenary Fellowships are now open and targeting outstanding Australian Researchers. These five year fellowships are valued at $1.25million

       

      _____________________________________________________________________________

      Research Project and Survey Requests

      Anti-viral Immunity in Asthma – Call for participants in Brisbane

      The LUNG AND ALLERGY RESEARCH CENTRE is conducting a research project on antiviral immunity in asthma to understand why asthmatic people suffer from worse colds and flus. We need people with and without asthma to donate 40mL of blood. Participation takes place at the PA hospital and takes only 15-30 minutes. Option for allergy testing with total 100mL blood donation.

      For more information please contact Liisa Murray | 07 3443 7133 | Flyer

       

      International Malignant Pleural Effusion Practice Survey

      In 2003, an international survey was conducted to gain an idea on the variations in pleurodesis practices for malignant pleural effusions in different parts of the world. The study provided useful data and highlighted areas of significant differences in practice that could be addressed with clinical trials.  In the last 12 years, malignant pleural disease management has dramatically changed especially with the increasing use of indwelling pleural catheters and medical thoracoscopy.  Given the options available researchers would like to see how opinions and practice vary across the world. (Lee, Rahman, Ahmed, Feller-Kopman, Sivakumar). 

      They would be most grateful if colleagues could find the time to complete the following survey which will take approximately 15 minutes to complete.

      To ensure that all information will remain confidential and anonymous, researchers will not record any personal information including IP addresses. You have the option of providing your email address if you would like to receive a copy of the analysed results. Email addresses will be recorded on a separate database to keep responses anonymous. Your email address will not be used for any other reason or correspondence.

      The survey can be found at http://www.tinyurl.com/pleuralsurvey
      Thank you!

      Austrailan Co-ordinator: Prof YC Gary Lee 

       

      The Breathing for Life Trial (BLT)

      BLT is a randomised trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.

      We are seeking volunteers with doctor diagnosed asthma, asthma symptoms or medication use in previous 12 months, 18 years of age or older, 12-22 weeks gestation, smokers and non-smokers.

      This trial will take place at;

      – John Hunter Hospital, Newcastle NSW
      – Royal Hospital for Women, Randwick NSW
      – Nepean Hospital, NSW
      – Royal Brisbane and Women’s Hospital, QLD
      – Royal North Shore Hospital, NSW
      – Canberra Hospital, ACT

      Click here to read more about this trial
      Participant Information Statement and Consent Form [PDF]

      For more information please contact Dr Megan Jensen: Ph (02) 4042 0130 | breathingforlifetrial@gmail.com | Facebook

      Venous Thrombo-Embolism Survey

      Dear Colleague,

      Our research team is conducting a brief survey to better understand how physicians currently approach the management of patients with suspected and proven venous thromboembolism. We are currently inviting physicians who manage patients with venous thromboembolism throughout Australia to take part. The results of the survey will provide valuable information to guideline developers and may help in the development of educational resources for physicians and trainees who manage this group of patients.

      We invite you to take part in a voluntary online survey, which will take approximately 10 minutes to complete.  There are no right or wrong answers to the questions in this survey.

      Ethics approval has been granted for this study by Melbourne Health (Approval number QA2015182) and there are no anticipated risks to you by taking part in this research. All survey responses will be anonymous and confidential. No personal information that could identify you is being collected and your email address will not be linked to your survey response. Your consent to participate in this study is implied by completing the survey.

      If you have any questions regarding this research, please do not hesitate to contact Dr Renee Manser or Mr Rory Wallace directly. Thank you in advance for participating.

      If you have any complaints about any aspect of the project, the way it is being conducted or any questions about your rights as a research participant, then you may contact Ms Jessica Turner, Manager Human Research Ethics Committees, Melbourne Health on (03) 9342 8530. You will need to tell Ms Turner the number or name of the project (see above).

      Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser. 

      Survey Link: https://www.surveymonkey.com/r/rmhvte

      Dr Renee Manser, Respiratory Physician, Department of Respiratory Medicine, The Royal Melbourne Hospital, Tel: 03 9342 7708
      Mr Rory Wallace, Medical Student, Department of Respiratory Medicine, The Royal Melbourne Hospital, Tel: 03 9342 7708
      A/Prof Louis Irving, Director of Respiratory & Sleep Medicine, The Royal Melbourne Hospital, Melbourne
      Dr Mary Ann Anderson, Haematologist, Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital

       
       
       
       
       

       

       

       

       
       
       
       
       
       
       
       
       

      .

      WHY JOIN US?

      Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

      By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

      X